Works matching IS 02780232 AND DT 2021 AND VI 39
Results: 534
The resistance mechanisms and treatment strategies of BTK inhibitors in B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 605, doi. 10.1002/hon.2933
- By:
- Publication type:
- Article
Combined tumor‐associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 625, doi. 10.1002/hon.2926
- By:
- Publication type:
- Article
A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 595, doi. 10.1002/hon.2929
- By:
- Publication type:
- Article
Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 697, doi. 10.1002/hon.2925
- By:
- Publication type:
- Article
Comparison of first‐line treatments of peripheral T‐cell lymphoma according to regimen: A systematic review and meta‐analysis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 664, doi. 10.1002/hon.2924
- By:
- Publication type:
- Article
Secondary primary malignancies in patients with multiple myeloma: A single institution experience.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 674, doi. 10.1002/hon.2923
- By:
- Publication type:
- Article
Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 639, doi. 10.1002/hon.2922
- By:
- Publication type:
- Article
On the relevance of immunodeficiency evaluation in haematological cancer.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 721, doi. 10.1002/hon.2921
- By:
- Publication type:
- Article
Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
- By:
- Publication type:
- Article
Outcomes of hematopoietic cell transplantation for transformed follicular lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 650, doi. 10.1002/hon.2917
- By:
- Publication type:
- Article
COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 712, doi. 10.1002/hon.2916
- By:
- Publication type:
- Article
IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 707, doi. 10.1002/hon.2915
- By:
- Publication type:
- Article
Lower incidence of clinical allergy with PEG‐asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG‐ASP in pediatric patients with acute lymphoblastic leukemia.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 687, doi. 10.1002/hon.2914
- By:
- Publication type:
- Article
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 680, doi. 10.1002/hon.2913
- By:
- Publication type:
- Article
Is race important in genomic classification of hematological neoplasms?
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 728, doi. 10.1002/hon.2909
- By:
- Publication type:
- Article
Successful early treatment combining remdesivir with high‐titer convalescent plasma among COVID‐19‐infected hematological patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 715, doi. 10.1002/hon.2908
- By:
- Publication type:
- Article
Racial disparities in hospitalization outcomes among adult multiple myeloma patients using the national inpatient sample (2016–2018).
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 724, doi. 10.1002/hon.2907
- By:
- Publication type:
- Article
Implication of immune cell signature of tumor microenvironment in diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 616, doi. 10.1002/hon.2905
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 593, doi. 10.1002/hon.2749
- Publication type:
- Article
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
- By:
- Publication type:
- Article
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 521, doi. 10.1002/hon.2906
- By:
- Publication type:
- Article
CD38 expression is an important prognostic marker in diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 483, doi. 10.1002/hon.2904
- By:
- Publication type:
- Article
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 589, doi. 10.1002/hon.2903
- By:
- Publication type:
- Article
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 580, doi. 10.1002/hon.2886
- By:
- Publication type:
- Article
RBCK1‐TRIB3 decelerated the progression of acute promyelocytic leukemia.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 567, doi. 10.1002/hon.2901
- By:
- Publication type:
- Article
Immunoglobulin replacement therapy discontinuation in patients with antibody deficiency secondary to hematological malignancy.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 584, doi. 10.1002/hon.2900
- By:
- Publication type:
- Article
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 570, doi. 10.1002/hon.2899
- By:
- Publication type:
- Article
Perirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 473, doi. 10.1002/hon.2902
- By:
- Publication type:
- Article
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 549, doi. 10.1002/hon.2896
- By:
- Publication type:
- Article
Downregulation of circ_0012152 inhibits proliferation and induces apoptosis in acute myeloid leukemia cells through the miR‐625‐5p/SOX12 axis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 539, doi. 10.1002/hon.2895
- By:
- Publication type:
- Article
Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 513, doi. 10.1002/hon.2888
- By:
- Publication type:
- Article
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 558, doi. 10.1002/hon.2898
- By:
- Publication type:
- Article
Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 498, doi. 10.1002/hon.2897
- By:
- Publication type:
- Article
Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta‐analysis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 448, doi. 10.1002/hon.2875
- By:
- Publication type:
- Article
Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 465, doi. 10.1002/hon.2871
- By:
- Publication type:
- Article
Reduced radiotherapy clinical benefit for primary Waldeyer's ring diffuse large B‐cell lymphoma in the rituximab era.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 490, doi. 10.1002/hon.2869
- By:
- Publication type:
- Article
Hepatitis C virus‐associated indolent B‐cell lymphomas: A review on the role of the new direct antiviral agents therapy.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 439, doi. 10.1002/hon.2862
- By:
- Publication type:
- Article
Long‐term follow‐up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 506, doi. 10.1002/hon.2835
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 437, doi. 10.1002/hon.2748
- Publication type:
- Article
Erratum.
- Published in:
- 2021
- Publication type:
- Correction Notice
Erratum.
- Published in:
- 2021
- Publication type:
- Correction Notice
Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR‐5195‐3p/GRB10 axis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 390, doi. 10.1002/hon.2874
- By:
- Publication type:
- Article
Intrahospital COVID‐19 infection outbreak management: Keep calm and carry on.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 431, doi. 10.1002/hon.2873
- By:
- Publication type:
- Article
Seroconversion and kinetic of anti SARS‐COV‐2 antibodies in 25 patients with hematological malignancies who recovered from SARS‐COV‐2 infection.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 428, doi. 10.1002/hon.2872
- By:
- Publication type:
- Article
Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 313, doi. 10.1002/hon.2868
- By:
- Publication type:
- Article
Mesenchymal stem cells enhance the impact of KIR receptor‐ligand mismatching on acute graft‐versus‐host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 380, doi. 10.1002/hon.2867
- By:
- Publication type:
- Article
Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 304, doi. 10.1002/hon.2865
- By:
- Publication type:
- Article
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 293, doi. 10.1002/hon.2864
- By:
- Publication type:
- Article
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 349, doi. 10.1002/hon.2863
- By:
- Publication type:
- Article